Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Greg Finn et. al. | ||||||||||||
Title | Identification of heregulin expression as a driver of a difficult-to-treat cancer phenotype and development of a prospective companion diagnostic for the heregulin-ErbB3 targeting drug seribantumab | ||||||||||||
|
|||||||||||||
URL | http://files.shareholder.com/downloads/AMDA-IWDM2/2127694404x0x892308/7BACAE03-69E0-423A-A4D5-8A19EFED7AE1/MM-121_AACR_Precision_Medicine_Poster_11May2016_FINAL.pdf | ||||||||||||
Abstract Text | AACR Precision Medicine Series: Targeting the Vulnerabilities of Cancer, May 2016, Abstract # A14 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|